(Online Study) Healthy Lifestyles for Bipolar Disorder
(HL Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores how two different healthy eating plans—time-restricted eating and the Mediterranean diet—affect people with bipolar disorder who are already on medication. Researchers aim to determine how these diets influence mood symptoms and overall quality of life. Participants will track their eating, sleep, and mood for two weeks, then follow one of the diets for eight weeks. This trial suits individuals with bipolar I or II disorder who have sleep concerns and are currently stable on their medication. As an unphased trial, it offers a unique opportunity to contribute to understanding how diet can improve life quality for those with bipolar disorder.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but it does require that your mood-stabilizing medication regimen has been stable for at least one month. Some medications that are contraindicated (not recommended) for fasting, like clozapine and certain diabetes medications, may affect eligibility.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research shows that both the Mediterranean diet and time-restricted eating (TRE) are safe and easy to follow. Studies have found that the Mediterranean diet, which emphasizes fruits, vegetables, whole grains, and healthy fats, can improve heart health and lower the risk of some cancers.
Time-restricted eating, which involves eating only during certain hours each day, is also generally safe. It can enhance metabolism and mood, and many people find it easy to maintain.
Overall, both diets have been studied and found to be safe with positive health benefits. Participants in these studies did not report major issues, making them promising options to consider.12345Why are researchers excited about this trial?
Researchers are excited about exploring healthy lifestyle changes like the Mediterranean diet and Time Restricted Eating (TRE) for managing bipolar disorder because they offer a non-pharmacological approach that could complement existing treatments like mood stabilizers and antipsychotics. Unlike the standard medications, which focus on altering brain chemistry, these lifestyle interventions aim to improve overall well-being through natural methods. The Mediterranean diet emphasizes nutrient-rich foods that support brain health, while TRE encourages better eating habits by limiting eating hours, potentially stabilizing mood and energy levels. Together, they represent a promising shift towards holistic management of bipolar disorder, which could enhance quality of life without the side effects often associated with medication.
What evidence suggests that this trial's treatments could be effective for bipolar disorder?
This trial will compare the Mediterranean diet and Time-Restricted Eating (TRE) as interventions for bipolar disorder. Research has shown that the Mediterranean diet, which participants in this trial may follow, can help reduce symptoms of mood disorders, such as bipolar disorder. This diet includes plenty of fruits, vegetables, whole grains, and lean proteins, and it can improve mental health by reducing depression and anxiety. It is also linked to a better overall quality of life.
Time-restricted eating (TRE), another intervention in this trial, involves consuming all meals within a specific 10-hour window each day. Early evidence suggests that TRE can benefit mood and metabolic health. Studies indicate that TRE can help regulate the body's internal clock, which might improve mood stability for people with bipolar disorder. Both the Mediterranean diet and TRE offer promising ways to manage symptoms alongside medication.12678Who Is on the Research Team?
Sheri L Johnson, PhD
Principal Investigator
University of California, Berkeley
Are You a Good Fit for This Trial?
This trial is for individuals with bipolar disorder who are currently on medication. Participants will track their eating, sleep, and mood for two weeks before being randomly assigned to one of two healthy eating plans: time-restricted eating or the Mediterranean diet.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Participants complete daily measures of eating, sleep, and mood for two weeks
Treatment
Participants are randomly assigned to either time-restricted eating or the Mediterranean diet for 8 weeks
Post-Treatment Assessment
Participants complete measures of symptoms and Quality of Life at the end of the food plan
Follow-up
Participants are monitored for sustained changes in symptoms and Quality of Life at 3, 6, and 12 months post-intervention
What Are the Treatments Tested in This Trial?
Interventions
- Mediterranean diet
- Time restricted eating
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, Berkeley
Lead Sponsor
Swinburne University of Technology
Collaborator
Deakin University
Collaborator
University of British Columbia
Collaborator
Salk Institute for Biological Studies
Collaborator
University College, London
Collaborator
Wellcome Trust
Collaborator